KUNWHA PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
||
| - | - |
|
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Managers | Title | Age | Since |
|---|---|---|---|
Jun-Su Lee
CEO | Chief Executive Officer | 51 | 18-12-06 |
Sung-Ho Jin
BRD | Director/Board Member | 61 | 01-02-28 |
Sun-Min Im
AUD | Comptroller/Controller/Auditor | 75 | 14-03-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 14-03-27 | |
Jong-Wuk Lee
BRD | Director/Board Member | 64 | 12-03-15 |
Kevin Bain
BRD | Director/Board Member | 66 | 12-12-12 |
ALVOGEN KOREA CO.,LTD, formerly KUN WHA PHARMACEUTICAL CO., LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company's products consist of remedies for hyperpotassemia, remedies for hypertension, steroid anti-inflammatory agents, analgesics, penicillins antibiotics, brain improvement agents, remedies for prostatism and others. On June 13, 2013, the Company sold its entire shares of Longstand International Limited, which is mainly engaged in the construction business, as well as GOJIN MOTORS, which is mainly engaged in the vehicle sales and maintenance service.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +20.73% | 43.57B | |
| +20.70% | 22.7B | |
| +11.68% | 14.32B | |
| +11.79% | 13.42B | |
| +45.30% | 11.83B | |
| -8.84% | 6.98B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.33% | 5.51B |
- Stock Market
- Equities
- Stock